<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001417'>X-linked</z:hpo> lymphoproliferative syndrome (XLP) is caused by mutations in SH2D1A, and is associated with overwhelming <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e>, <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, <z:hpo ids='HP_0004313'>hypogammaglobulinemia</z:hpo>, and B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the frequency of SH2D1A mutations in males who present with B NHL is unknown </plain></SENT>
<SENT sid="2" pm="."><plain>Five cases of XLP were diagnosed among 158 males presenting with B NHL (approximately 3.2%) </plain></SENT>
<SENT sid="3" pm="."><plain>Four of the patients had two episodes of B NHL and one had a single episode of B NHL followed by aggressive <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Prospective screening for XLP in males with B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> at the time of initial diagnosis should be considered </plain></SENT>
<SENT sid="5" pm="."><plain>Pediatr <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">Blood Cancer</z:e>. Â© 2013 Wiley Periodicals, Inc </plain></SENT>
</text></document>